Advanced Nanotechnology Approaches As Emerging Tools in Cellular-Based Technologies

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2022 Jul 11

PMID 35816248

Authors

Mehdi Soleymani-Goloujeh

Samaneh Hosseini

Mohamadreza Baghaban Eslaminejad

Affiliations

Soon will be listed here.

Abstract

Stem cells are valuable tools in regenerative medicine because they can generate a wide variety of cell types and tissues that can be used to treat or replace damaged tissues and organs. However, challenges related to the application of stem cells in the scope of regenerative medicine have urged scientists to utilize nanomedicine as a prerequisite to circumvent some of these hurdles. Nanomedicine plays a crucial role in this process and manipulates surface biology, the fate of stem cells, and biomaterials. Many attempts have been made to modify cellular behavior and improve their regenerative ability using nano-based strategies. Notably, nanotechnology applications in regenerative medicine and cellular therapies are controversial because of ethical and legal considerations. Therefore, this review describes nanotechnology in cell-based applications and focuses on newly proposed nano-based approaches. Cutting-edge strategies to engineer biological tissues and the ethical, legal, and social considerations of nanotechnology in regenerative nanomedicine applications are also discussed.

Citing Articles

Nanotherapeutic and Nano-Bio Interface for Regeneration and Healing.

Kumar R, Igwegbe C, Khandel S Biomedicines. 2025; 12(12.

PMID: 39767834 PMC: 11673698. DOI: 10.3390/biomedicines12122927.

References

Afshar L, Aghayan H, Sadighi J, Arjmand B, Hashemi S, Basiri M . Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran. Stem Cell Res Ther. 2020; 11(1):396. PMC: 7489032. DOI: 10.1186/s13287-020-01916-z. View

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M . Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29(4):341-5. DOI: 10.1038/nbt.1807. View

Aswendt M, Henn N, Michalk S, Schneider G, Steiner M, Bissa U . Novel bimodal iron oxide particles for efficient tracking of human neural stem cells in vivo. Nanomedicine (Lond). 2015; 10(16):2499-512. DOI: 10.2217/NNM.15.94. View

Baei P, Hosseini M, Baharvand H, Pahlavan S . Electrically conductive materials for in vitro cardiac microtissue engineering. J Biomed Mater Res A. 2020; 108(5):1203-1213. DOI: 10.1002/jbm.a.36894. View

Barrow M, Taylor A, Carrion J, Mandal P, Park B, Poptani H . Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast. Contrast Media Mol Imaging. 2016; 11(5):362-370. DOI: 10.1002/cmmi.1700. View

Bhat R, Bissell M . Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype. Wiley Interdiscip Rev Dev Biol. 2014; 3(2):147-63. DOI: 10.1002/wdev.130. View

Bondi M, Azzolina A, Craparo E, Lampiasi N, Capuano G, Giammona G . Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. J Drug Target. 2007; 15(4):295-301. DOI: 10.1080/10611860701324698. View

Boulaiz H, Alvarez P, Ramirez A, Marchal J, Prados J, Rodriguez-Serrano F . Nanomedicine: application areas and development prospects. Int J Mol Sci. 2011; 12(5):3303-21. PMC: 3116192. DOI: 10.3390/ijms12053303. View

Bulte J . In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol. 2009; 193(2):314-25. PMC: 2857985. DOI: 10.2214/AJR.09.3107. View

10.

Bulte J, Kraitchman D . Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol. 2004; 5(6):567-84. DOI: 10.2174/1389201043376526. View

11.

Bulte J, Kraitchman D . Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17(7):484-99. DOI: 10.1002/nbm.924. View

12.

Bulte J, Zhang S, van Gelderen P, Herynek V, Jordan E, Duncan I . Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A. 1999; 96(26):15256-61. PMC: 24807. DOI: 10.1073/pnas.96.26.15256. View

13.

Chan S, Harris J . Adam's fibroblast? The (pluri)potential of iPCs. J Med Ethics. 2008; 34(2):64-6. DOI: 10.1136/jme.2007.023937. View

14.

Chemaly E, Yoneyama R, Frangioni J, Hajjar R . Tracking stem cells in the cardiovascular system. Trends Cardiovasc Med. 2005; 15(8):297-302. DOI: 10.1016/j.tcm.2005.09.004. View

15.

Choi Y, Yi H, Kim S, Cho D . 3D Cell Printed Tissue Analogues: A New Platform for Theranostics. Theranostics. 2017; 7(12):3118-3137. PMC: 5566110. DOI: 10.7150/thno.19396. View

16.

Cicha I, Chauvierre C, Texier I, Cabella C, Metselaar J, Szebeni J . From design to the clinic: practical guidelines for translating cardiovascular nanomedicine. Cardiovasc Res. 2018; 114(13):1714-1727. PMC: 6198738. DOI: 10.1093/cvr/cvy219. View

17.

Corot C, Robert P, Idee J, Port M . Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006; 58(14):1471-504. DOI: 10.1016/j.addr.2006.09.013. View

18.

Cromer Berman S, Kshitiz , Wang C, Orukari I, Levchenko A, Bulte J . Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med. 2012; 69(1):255-62. PMC: 3366052. DOI: 10.1002/mrm.24216. View

19.

Engel E, Michiardi A, Navarro M, Lacroix D, Planell J . Nanotechnology in regenerative medicine: the materials side. Trends Biotechnol. 2007; 26(1):39-47. DOI: 10.1016/j.tibtech.2007.10.005. View

20.

Engler A, Sen S, Sweeney H, Discher D . Matrix elasticity directs stem cell lineage specification. Cell. 2006; 126(4):677-89. DOI: 10.1016/j.cell.2006.06.044. View